Supplemental Disclosure of Cash Flow Information (Tables)

9 Months Ended

Sep. 30, 2018

The supplemental cash flow information for the nine months ended September 30, 2018 and 2017 (unaudited) is as follows:

	Nine Months Ended September 30,
	2018			2017
Cash paid for interest	$	302,308		$	1,106,835
Cash paid for income taxes	$	20,000		$	506,313

Acquisition of Jamestown Regional Medical Center:
Cash	$	-		$	-
Inventory	$	450,682		$	-
Prepaid expenses and other current assets	$	310,385		$	-
Property and equipment	$	7,347,468		$	-
Intangible assets	$	486,716		$	-
Accrued expenses	$	(193,966	)	$	-

Non-cash investing and financing activities:
Exchange of preferred stock for convertible debentures and warrants	$	-		$	10,734,336
Cashless exercise of warrants	$	4,619,150		$	-
Exchange of convertible debentures for convertible debentures and warrants	$	-		$	-
Exchange of debentures for Series I-2 Preferred Stock	$	1,420		$	-
Services and severance settled through issuance of common stock	$	-		$	161,003
Note payable, warrants, and accrued expenses settled through issuance of common stock	$	-		$	440,000
Note payable and accrued expenses settled through issuance of Series J Preferred Stock	$	250,000			-
Exchange of Series H Preferred Stock for debentures	$	-		$	2,695,760
Series F Preferred Stock issued for business acquisition	$	-		$	174,097
Debentures converted into common stock	$	8,085,342		$	4,064,162
OID from issuance of debentures	$	1,920,000		$	-
Conversions of shares of Preferred Stock into common stock	$	633,100		$	-
Conversions of shares of Series H Preferred Stock into common stock	$	50,000		$	-
Deemed dividend for trigger of down round provision feature	$	17,942,578		$	53,341,619